All Articles

Private equity wants AI's power without the data risk. Navatar's new governed framework with Salesforce and Claude offers a tightly controlled solution.

SDC's plan to merge Sentosa and Brani is more than a tourism upgrade; it's a strategic move to double visitor numbers and set a global standard for sustainable, tech-integrated leisure destinations.

Danish innovator Oticon is challenging the industry's focus on noise reduction with its new Dual AI, aiming to restore natural, balanced soundscapes.

Nordic office outfitter Martela issues a stark profit warning, revealing deep market uncertainty and what it means for the future of corporate spending.

Computer Modelling Group reports a 60% profit drop after a major client loss, yet initiates a $20M share buyback. A sign of confidence or a risky gamble?

A biotech's new funding offers a glimmer of hope for a novel cancer therapy, but a look at the books reveals a desperate race against time and capital.

Cavvy Energy's stunning Q2 results are more than a commodity boom. A closer look reveals a story of strategic resilience and a powerful midstream pivot.

InfiMaker's new K1 desktop CNC combines true 5-axis machining with AI software, aiming to disrupt manufacturing. But can it deliver on its Kickstarter promise?

A traditional construction firm is set to become a pure-play AI robotics company on the NYSE. Why is JFB betting it all on XTEND's autonomous technology?

MetalCloak launches a new Tacoma suspension lineup, moving beyond simple lifts to offer three distinct, engineered systems for every type of owner.

Two Harbors fires back at a "baseless" lawsuit from UWM, exposing a financial firestorm centered on a massive derivatives loss and a failed merger.

COSCIENS Biopharma boasts a dramatic financial turnaround, but its strategic move to exit SEC oversight shifts the risk-reward calculus for investors.

HCIactive's 'Human Experience Engineering' promises an AI-driven fix for healthcare's notorious complexity. But can it earn trust in a crowded, high-stakes field?

As students face a choice between their health and education, one foundation offers direct aid. But does this agile approach mask a deeper systemic failure?

With new HKEX rules mandating rigorous board reviews, companies are at a crossroads. Specialist firms like GreenCo offer a path beyond compliance.

RBC and BMO's $2 billion sale of Moneris isn't just a big payday. It's a strategic retreat from a complex market, fueling a new chapter for Canadian commerce.

A family-owned filter maker's acquisition of a century-old supplier isn't just a deal; it's a masterclass in operational expansion and customer retention.

Aardvark Therapeutics faces a pivotal moment as an FDA clinical hold halts its lead drug trial, leaving the Prader-Willi Syndrome community waiting.

Jatagan Security's new UL Solutions verification for its reporting process could finally bring clarity to an industry plagued by unsubstantiated claims.

CanNor's latest funding is not just about infrastructure; it's a strategic play on Indigenous-led economic sovereignty and the future of Canada's North.